NasdaqGS - Nasdaq Real Time Price • USD
Seres Therapeutics, Inc. (MCRB)
As of 1:58 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ARKOWITZ DAVID A. Chief Financial Officer | Sale | Feb 16, 2024 | 182,442 |
CLOGHESSY PAULA Officer | Sale | Oct 30, 2023 | 45,684 |
DERE WILLARD H Director | Stock Award(Grant) | Jul 5, 2022 | 31,746 |
DESROSIER THOMAS J J.D. Officer | Sale | Feb 16, 2024 | 120,577 |
EGE DAVID S. Chief Technology Officer | Sale | Feb 16, 2024 | 73,856 |
HENN MATTHEW R Officer | Sale | Feb 16, 2024 | 63,436 |
KENDER RICHARD N Director | Stock Award(Grant) | Jul 5, 2022 | 63,492 |
SHAFF ERIC D Chief Executive Officer | Sale | Feb 16, 2024 | 135,321 |
VON MOLTKE LISA M.D. Officer | Sale | Feb 16, 2024 | 16,988 |
YOUNG TERESA L. Officer | Sale | Feb 16, 2024 | 15,705 |
Related Tickers
AKBA Akebia Therapeutics, Inc.
1.3800
+1.47%
RAPT RAPT Therapeutics, Inc.
8.11
+3.18%
XFOR X4 Pharmaceuticals, Inc.
1.3000
-4.40%
PDSB PDS Biotechnology Corporation
3.2400
+8.36%
TGTX TG Therapeutics, Inc.
14.51
+2.91%
ARDX Ardelyx, Inc.
6.54
+0.38%
IBRX ImmunityBio, Inc.
5.43
+9.82%
AXSM Axsome Therapeutics, Inc.
73.32
+3.12%
IOVA Iovance Biotherapeutics, Inc.
11.88
+4.90%
BLUE bluebird bio, Inc.
0.9785
+2.60%